Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non-SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real-world meta-analysis of 4 observational databases (OBSERVE-4D).
Diabetes Obes Metab. 2018 Nov;20(11):2585-2597. doi: 10.1111/dom.13424. Epub 2018 Jun 25.
Diabetes Obes Metab. 2018.
PMID: 29938883
Free PMC article.